Micah Redding — faith in humanity's future


Still looking for an apartment while staying with a guy I knew from school. I’ve got a particular one I definitely want. Hopefully, everything will work out, and I’ll talk to the land-lady on Wednesday.

We’ll see…



St0ck For Your Review - FCPG<br/><br/>Current Profile<br/>Faceprint Global Solutions (FCPG) <br/>Current Price $0.15<br/><br/><br/>A U.S. based-company dedicated to the goal of <br/>bringing effective security solutions to the marketplace.<br/><br/>With violent and white-collar terrorism on the rise, <br/>companies are starving for innovative security solutions. <br/><br/>FCPG is set to bring hot new security solutions to <br/>the industry, with currently over 40 governmental and <br/>non-governmental contracts, being negotiated.<br/><br/>Please Review Exactly What this Company Does.<br/><br/>Why consider Faceprint Global Solutions (FCPG)? <br/><br/>Faceprint Global Solutions (FCPG) holds the exclusive <br/>marketing rights from Keyvelop, to sell the world�s <br/>leading encryption technology to be distributed directly <br/>to the Healthcare industry in North America.<br/><br/>Faceprint Global Solutions has completed its biometric <br/>software that recognizes facial features of individuals <br/>entering and leaving through airports, ship yards, banks, <br/>large buildings, etc. <br/><br/>FCPG acquired Montreal-based Apometrix Technologies, <br/>which enhances the companies mission of being a <br/>full-service provider to the multi-application smart <br/>card industry. The North American market appears ready <br/>for significant expansion of price-competitive, proven, <br/>multi-application solutions on smart cards. Apometrix's <br/>forecast of over 300 customers and sales of more than $50 <br/>million in North America over the next five years, appears <br/>very realistic, according to company management. <br/><br/>Faceprint Global Solutions is currently in contract negotiations <br/>with over 40 governmental agencies and businesses seeking to use <br/>their encryption, biometric, and smart-card technologies.<br/><br/>Breaking News for Faceprint Global Solutions (FCPG) <br/><br/>Faceprint Global Solutions (FCPG) is pleased to announce that <br/>IBM will now offer the world�s leading encryption software to <br/>its major Healthcare clients in North America.<br/><br/>With FCPG owning the exclusive North American rights to distribute <br/>the worlds leading encryption and transmission software developed by <br/>Keyvelop, FCPG is poised to capture large volumes of sales generated <br/>by customers currently using IBM�s software in the healthcare and other industries.<br/>�This is a very positive move for FCPG and for Keyvelop,� said FCPG <br/>CEO Pierre Cote. �We are very happy about the decision to go with IBM. <br/>This is a continuation of the progress made by everyone associated <br/>with FCPG and its partners.�<br/><br/>Buell Duncan, IBM's general manager of ISV &amp; Developer Relations commented, <br/>�Collaborating with Keyvelop will ensure that we develop open solutions <br/>that are easy to maintain and cost effective for our customers in the <br/>healthcare and life sciences industry.�<br/><br/>Among other things, this new software technology which is currently <br/>being used by a number of European healthcare companies, is used to <br/>send any file, regardless of format or size. Encryption keys, evidence <br/>of transmission integrity with fingerprint calculation, time-stamping <br/>of all actions and status record updating, pre-checking sender and <br/>receiver identities, validating file opening dates are part of Keyvelop features.<br/>About FacePrint Global Solutions, Inc.<br/><br/>FCPG operates a business, which develops and delivers a variety of <br/>technology solutions, including biometric software applications on <br/>smart cards and other support mediums (apometric solutions). FCPG�s <br/>products provide biometric solutions for identity authentication and a <br/>host of smart card- and biometrics-related hardware peripherals and <br/>software applications. Apometrix, FCPG�s wholly-owned subsidiary, combines <br/>on-card or in-chip multi-application management solutions with best-of-breed <br/>�in-card matching� biometrics. Keyvelop�s secure digital envelope solution <br/>and Apometrix�s on-card biometrics work together to produce the winning <br/>combination in the fields of security, traceability and identity management. <br/>Conclusion:<br/><br/>The examples above show the Awesome, Earning Potential of little known <br/>Companies That Explode onto Investor�s Radar Screens. This sto,ck will <br/>not be a Secret for long. Then You May Feel the Desire to Act Right Now! <br/>And Please Watch This One Trade! <br/><br/>GO FCPG!<br/><br/>Disclaimer:<br/>Information within this email contains "forwardlooking statements" within<br/>the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of<br/>the Securities Exchange Act of 1934. Any statements that express or involve<br/>discussions with respect to predictions, expectations, beliefs,<br/>plans, projections, objectives, goals, assumptions or future events or<br/>performance are not statements of historical fact and may be "forward<br/>looking statements". "Forward |ooking statements" are based on<br/>expectations, estimates and projections at the time the statements are made<br/>that involve a number of risks and uncertainties which could cause actual<br/>results or events to differ materially from those presently anticipated.<br/>We were paid a sum of three thousand USD to disseminate this information from <br/>ir marketing. Forward loking statements in this action may be identified through <br/>the use of words such as "projects", "foresee", "expects", "will", "anticipates",<br/>"estimates", "believes", "understands" or that by statements indicating<br/>certain actions "may", "could", or "might" occur. Risk factors include<br/>general economic and business conditions, the ability to acquire and develop<br/>specific projects, the ability to fund operations and changes in consumer<br/>and business consumption habits and other factors overwhich the company has<br/>little or no control. The publisher of this newsletter does not represent<br/>that the information contained herein are true and correct.